NEW YORK (GenomeWeb News) – GeneGo said today that GlaxoSmithKline has extended a licensing agreement for its systems biology software tools.
 
The expanded agreement provides GSK’s researchers in bioinformatics, R&D, and clinical studies with global access to GeneGo’s MetaCore, MapEditor, and MetaBase informatics tools.
 
GSK will use MetaCore, a collection of pathway maps and network models, as “a repository of all types of experimental data as well as resulting analyses,” GeneGo said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.